Syros Pharmaceuticals Inc (NAS:SYRS)
$ 0.2159 0.013 (6.41%) Market Cap: 5.79 Mil Enterprise Value: 7.39 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 25/100

Q2 2020 Syros Pharmaceuticals Inc Earnings Call Transcript

Aug 06, 2020 / 12:30PM GMT
Release Date Price: $120.3 (+6.65%)
Operator

Good morning, and welcome to Syros Pharmaceuticals' Second Quarter 2020 Financial Results Conference Call. (Operator Instructions) This call is being webcast live on the Investors and Media section of Syros' website at www.syros.com. Please be advised that today's call is being recorded. (Operator Instructions)

At this time, I would now like to turn the call over to Naomi Aoki, Vice President of Corporate Communications and Investor Relations at Syros.

Naomi Aoki
Syros Pharmaceuticals, Inc. - VP of Corporate Communications & IR

(technical difficulty)

pleased with our second quarter 2020 financial results, along with anticipated future milestones and recent accomplishments. This release is available on the Investors and Media section of Syros' website at www.syros.com. We will begin the call with prepared remarks by Dr. Nancy Simonian, our Chief Executive Officer; Dr. David Roth, our Chief Medical Officer; and Joe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot